share_log

Lipella Pharmaceuticals Announces Update On Phase 2a Trial Of LP-310 In Oral Lichen Planus; Three Participants Completed The Four-week Treatment, Says Treatment Was Well Tolerated And Had No Unpleasant Taste

Benzinga ·  Sep 24 08:16
Lipella Pharmaceuticals Announces Update On Phase 2a Trial Of LP-310 In Oral Lichen Planus; Three Participants Completed The Four-week Treatment, Says Treatment Was Well Tolerated And Had No Unpleasant Taste
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment